Stay updated on Aflibercept vs Bevacizumab vs Ranibizumab for DME Clinical Trial
Sign up to get notified when there's something new on the Aflibercept vs Bevacizumab vs Ranibizumab for DME Clinical Trial page.
Latest updates to the Aflibercept vs Bevacizumab vs Ranibizumab for DME Clinical Trial page
- Check7 days agoChange DetectedThe website has been updated from version 2.10.2 to 2.10.3.SummaryDifference0.0%
- Check14 days agoNo Change Detected
- Check21 days agoNo Change Detected
- Check28 days agoChange DetectedThe website has been updated from version 2.10.0 to 2.10.2, indicating new features or improvements.SummaryDifference0.0%
- Check35 days agoNo Change Detected
- Check49 days agoChange DetectedThe website has been updated to version 2.10.0, adding two more study numbers and indicating that the study now has 90 locations, while the previous version 2.9.7 has been removed.SummaryDifference0.3%
- Check57 days agoChange DetectedThe website has been updated to Revision v2.9.7 from v2.9.6.SummaryDifference0.0%
- Check70 days agoChange DetectedThe value of Revision has been updated from v2.9.5 to v2.9.6, indicating a recent change in the webpage content.SummaryDifference0.0%
- Check76 days agoChange DetectedThe value of Revision has been updated from v2.9.3 to v2.9.5, indicating a recent change in the webpage content related to the study details of a Comparative Effectiveness Study of Intravitreal Aflibercept, Bevacizumab, and Ranibizumab for Diabetic Macular Edema.SummaryDifference0.0%
Stay in the know with updates to Aflibercept vs Bevacizumab vs Ranibizumab for DME Clinical Trial
Enter your email address, and we'll notify you when there's something new on the Aflibercept vs Bevacizumab vs Ranibizumab for DME Clinical Trial page.